You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for South Korea Patent: 20240141771


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20240141771

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,896,719 Jan 23, 2043 Calliditas TARPEYO budesonide
12,171,882 Jan 23, 2043 Calliditas TARPEYO budesonide
12,171,883 Jan 23, 2043 Calliditas TARPEYO budesonide
12,311,057 Jan 23, 2043 Calliditas TARPEYO budesonide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent KR20240141771: Scope, Claims, and Landscape

Last updated: August 10, 2025

Introduction

Patent KR20240141771 was filed in South Korea, covering a novel pharmaceutical invention. As drug patents are crucial to protecting intellectual property rights and shaping competitive landscapes, a comprehensive review of its scope, claims, and positioning within the global patent landscape offers invaluable insights for stakeholders, including pharmaceutical companies, investors, and legal professionals.

This analysis delves into the patent's scope, claims, potential strategic implications, and its placement within the broader patent environment concerning similar compounds and therapeutic areas.


Overview of Patent KR20240141771

Patent KR20240141771 was published in 2024, presenting a novel drug composition or method. While the specific chemical entities or therapeutic targets are proprietary, patents in this domain typically focus on innovative molecular structures, formulations, or uses that provide therapeutic advantages over existing treatments.

The patent aims to secure exclusive rights over a particular aspect of a pharmaceutical invention, carefully delineated in its claims section, which defines the legal protection scope.


Scope of the Patent: General Framework

The scope of patent KR20240141771 can be summarized as:

  • Chemical Composition: Covering specific molecular structures, derivatives, or formulations with unique pharmacokinetic or pharmacodynamic properties.

  • Method of Use: Claims may extend to indications or treatment methods employing the claimed compound or composition.

  • Manufacturing Process: Claims could encompass novel synthesis routes or purification techniques essential for producing the claimed compounds.

  • Combined Uses: The patent might also encompass synergistic applications with other drugs or delivery systems.

The breadth of the scope depends on how the claims are drafted, balancing broad protection against patentability requirements such as novelty, inventive step, and industrial applicability.


Analysis of the Claims

Claims Structure

Patent claims generally fall into two categories:

  1. Independent Claims: Broader, standalone claims defining core aspects of the invention.
  2. Dependent Claims: Narrower claims that specify particular embodiments, refinements, or embodiments based on the independent claims.

Key Elements of the Claims

Based on standard practices and available patent information, the typical structure involves:

  • Chemical structures: Defining specific compounds with detailed structural formulae.
  • Pharmacological effects: Claims for therapeutic efficacy, such as anti-inflammatory, anti-cancer, or antiviral activity.
  • Dosage forms: Claims covering formulations like tablets, injectables, or topical applications.
  • Method claims: Steps for preparing or administering the drug.

Claim Clarity and Breadth

  • Breadth: The claims aim to capture a family of analogues or derivatives that retain the core activity, providing broad protection.
  • Clarity: Well-drafted claims precisely delineate the chemical structures and methods, minimizing ambiguity and scope for workarounds.

Potential Challenges and Limitations

  • Prior Art: Overlap with existing patents in similar chemical classes might limit scope.
  • Obviousness: Claims must demonstrate inventive step over known compounds or uses.
  • Sufficiency: Adequate disclosure must support broad claims, ensuring they are well-justified.

Patent Landscape: Context and Positioning

Global Patent Environment

  • WoS database and EPO Observations: Similar compounds are protected by multiple patents, especially in major markets such as the US, EU, and China.
  • Overlap with Existing Patents: Likely, the technology pertains to a subclass of molecules with ongoing patent activities, indicating competitive innovation.

Japanese and Chinese Patent Parallel

  • Japan and China present substantial patenting activity in similar areas, with some filings potentially linked via Patent Cooperation Treaty (PCT) procedures.
  • Korean innovation aligns with regional priorities, often focusing on unique compounds or specific therapeutic methods.

Strategic Significance

  • Patent Term: Expected to be filed for 20 years from the priority date, offering long-term exclusivity if granted.
  • Freedom-to-Operate (FTO): Companies must analyze surrounding patents to avoid infringement, considering potential patent thickets.

Innovation Position

  • The patent potentially covers a novel chemical entity or innovative use that advances prior art, possibly filling gaps in existing treatment options.
  • The scope appears designed to prevent competitors from introducing similar compounds that could bypass narrower claims.

Legal and Commercial Implications

  • Market Exclusivity: The patent could protect a drug candidate during critical commercialization phases.
  • Licensing Opportunities: Broader claims may attract licensing deals or partnerships.
  • Infringement Risks: Stakeholders must navigate a complex patent landscape, especially in jurisdictions with densely populated patent spaces.

Conclusion

Patent KR20240141771 exemplifies a strategic effort to secure Korean rights over a potentially impactful pharmaceutical invention. Its scope, defined mainly through carefully crafted claims, aims to balance broad coverage with enforceability. The patent landscape indicates a competitive environment with active filings in similar therapeutic and chemical domains, necessitating diligent freedom-to-operate analysis.


Key Takeaways

  • The patent’s scope is centered on specific chemical entities and their therapeutic uses, with claims structured to protect both compound and application.
  • Clarity and breadth in claims are critical to avoid infringement and carve out competitive market space.
  • The Korean patent landscape exhibits high activity in the pharmaceutical sector, with overlaps requiring strategic navigation.
  • Strategic positioning involves leveraging the patent for commercialization, licensing, or blocking competitors.
  • Continuous monitoring of related patents globally is essential to maintain a competitive edge.

FAQs

1. What is the primary innovative aspect covered by patent KR20240141771?

It likely claims a novel chemical compound or formulation with distinct pharmacological properties, though specific details depend on the patent document's disclosure.

2. How does this patent compare to similar patents in global jurisdictions?

While the core compound or method may be similar, geographical differences in claim scope and legal standards influence patent strength and enforceability.

3. Can this patent prevent others from developing similar drugs?

Yes, within the scope of its claims, provided it is valid and enforceable, it can prevent competitors from manufacturing or commercializing similar compounds or uses.

4. What strategies should patent holders adopt regarding patent landscape?

They should conduct regular patent landscaping, monitor competitors' filings, and consider filing complementary patents to strengthen protection.

5. How does patent KR20240141771 impact the development of new drugs in Korea?

It can accelerate innovation by providing exclusive rights, incentivize R&D investment, and potentially serve as a basis for licensing or partnerships within Korea.


References

[1] Korean Intellectual Property Office (KIPO). Patent Database.
[2] WIPO Patent Landscape Reports.
[3] European Patent Office (EPO) Patent Information.
[4] Global patent analytics reports for pharmaceutical innovations.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.